U.S. market Closed. Opens in 16 hours 51 minutes

ENFN | Enfusion, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue174.53M150.35M111.70M79.56M59.03M
Cost of Revenue57.64M47.10M31.84M21.36M16.96M
Gross Profit116.89M103.25M79.86M58.21M42.07M
Operating Expenses104.95M115.21M355.74M52.13M28.20M
Selling, General & Admin85.05M98.05M202.34M45.81M24.05M
Research & Development19.89M17.16M153.40M6.32M4.15M
Other Operating Expenses-2.10M-638.00K-1.19M82.00K-3.00K
Operating Income11.95M-11.96M-275.88M6.07M13.87M
Other Expenses / Income-464.00K-225.00K-5.78M-1.58M-727.00K
Before Tax Income11.48M-12.19M-281.66M4.49M13.14M
Income Tax Expenses2.23M1.07M579.00K433.00K486.00K
Net Income6.03M-13.26M-282.24M4.06M12.66M
Interest Expenses1.64M413.00K4.59M1.66M724.00K
Basic Shares Outstanding88.20M85.39M65.58M113.05M113.05M
Diluted Shares Outstanding129.43M85.39M65.58M113.05M113.05M
EBITDA20.54M-5.62M-273.09M8.45M15.02M
EBITDA Margin11.77%-3.74%-244.49%10.62%25.45%
EBIT9.90M-11.78M-277.07M6.16M13.87M
EBIT Margin5.67%-7.83%-248.05%7.74%23.49%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙